Circulating tumour cells (CTCs) are active participants in the metastasis process and account for ∼90% of all cancer deaths. As CTCs are admixed with a very large amount of erythrocytes, leukocytes, and platelets in blood, CTCs are very rare, making their isolation, capture, and detection a major technological challenge. Microfluidic technologies have opened‐up new opportunities for the screening of blood samples and the detection of CTCs or other important cancer biomarker‐proteins. In this study, the authors have reviewed the most recent developments in microfluidic devices for cells/biomarkers manipulation and detection, focusing their attention on immunomagnetic‐affinity‐based devices, dielectrophoresis‐based devices, surface‐plasmon‐resonance microfluidic sensors, and quantum‐dots‐based sensors.
Emerging microfluidic devices for cancer cells/biomarkers manipulation and detection
V. H. Perez‐Gonzalez,R. C. Gallo-Villanueva,S. Camacho-Léon,Jose Gomez-Quinones,José Manuel Rodríguez-Delgado,S. Martínez-Chapa
Published 2016 in IET Nanobiotechnology
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
IET Nanobiotechnology
- Publication date
2016-10-01
- Fields of study
Biology, Medicine, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-23 of 23 citing papers · Page 1 of 1